U.S. Oral Solid Dosage Contract Manufacturing Market Size & Outlook
U.S. oral solid dosage contract manufacturing market, 2018-2030 (US$M)
Related Markets
U.S. oral solid dosage contract manufacturing market highlights
- The U.S. oral solid dosage contract manufacturing market generated a revenue of USD 10,878.8 million in 2023 and is expected to reach USD 16,426.4 million by 2030.
- The U.S. market is expected to grow at a CAGR of 6.1% from 2024 to 2030.
- In terms of segment, tablets was the largest revenue generating product in 2023.
- Capsules is the most lucrative product segment registering the fastest growth during the forecast period.
Oral solid dosage contract manufacturing market data book summary
| Market revenue in 2023 | USD 10,878.8 million |
| Market revenue in 2030 | USD 16,426.4 million |
| Growth rate | 6.1% (CAGR from 2023 to 2030) |
| Largest segment | Tablets |
| Fastest growing segment | Capsules |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tablets, Capsules, Powders, Granules |
| Key market players worldwide | Catalent Inc, Lonza Group Ltd, Boehringer Ingelheim, Jubilant Pharmova, Novacyt SA, Thermo Fisher Scientific Inc, Recipharm, CordenPharma, Siegfried Holding AG, Piramal Pharma Solutions, AbbVie Inc |
Other key industry trends
- In terms of revenue, U.S. accounted for 29.8% of the global oral solid dosage contract manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. oral solid dosage contract manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 16,426.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oral Solid Dosage Contract Manufacturing Market Scope
Oral Solid Dosage Contract Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. oral solid dosage contract manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oral solid dosage contract manufacturing market will help companies and investors design strategic landscapes.
Tablets was the largest segment with a revenue share of 32.17% in 2023. Horizon Databook has segmented the U.S. oral solid dosage contract manufacturing market based on tablets, capsules, powders, granules covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing R&D investments, growing drug development costs, expensive raw ingredients, and a rising need for oral solid dosage products are some of the factors driving numerous pharmaceutical entities in the U.S. to outsource significant aspects of the drug development process.
In addition, rapid growth in emerging areas of medicine, such as personalized medicine, orphan drugs, and biosimilars, is expected to propel the growth of oral solid dosage contract manufacturing market in the U.S.
Reasons to subscribe to U.S. oral solid dosage contract manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. oral solid dosage contract manufacturing market databook
-
Our clientele includes a mix of oral solid dosage contract manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. oral solid dosage contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. oral solid dosage contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. oral solid dosage contract manufacturing market size, by product, 2018-2030 (US$M)
U.S. Oral Solid Dosage Contract Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
